Literature DB >> 21454675

Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function.

Yiru Xu1, Wei Xia, Dustin Baker, Jin Zhou, Hyuk Chol Cha, John J Voorhees, Gary J Fisher.   

Abstract

Protein tyrosine phosphorylation is a ubiquitous, fundamental biochemical mechanism that regulates essential eukaryotic cellular functions. The level of tyrosine phosphorylation of specific proteins is finely tuned by the dynamic balance between protein tyrosine kinase and protein tyrosine phosphatase activities. Hepatocyte growth factor receptor (also known as Met), a receptor protein tyrosine kinase, is a major regulator of proliferation, migration, and survival for many epithelial cell types. We report here that receptor-type protein tyrosine phosphatase β (RPTP-β) specifically dephosphorylates Met and thereby regulates its function. Expression of RPTP-β, but not other RPTP family members or catalytically inactive forms of RPTP-β, reduces hepatocyte growth factor (HGF)-stimulated Met tyrosine phosphorylation in HEK293 cells. Expression of RPTP-β in primary human keratinocytes reduces both basal and HGF-induced Met phosphorylation at tyrosine 1356 and inhibits downstream MEK1/2 and Erk activation. Furthermore, shRNA-mediated knockdown of endogenous RPTP-β increases basal and HGF-stimulated Met phosphorylation at tyrosine 1356 in primary human keratinocytes. Purified RPTP-β intracellular domain preferentially dephosphorylates purified Met at tyrosine 1356 in vitro. In addition, the substrate-trapping mutant of RPTP-β specifically interacts with Met in intact cells. Expression of RPTP-β in human primary keratinocytes reduces HGF induction of VEGF expression, proliferation, and motility. Taken together, the above data indicate that RPTP-β is a key regulator of Met function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454675      PMCID: PMC3091207          DOI: 10.1074/jbc.M110.212597

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

2.  Autocrine production of biologically active hepatocyte growth factor (HGF) by injured human skin.

Authors:  Fariba Nayeri; Junjang Xu; Avni Abdiu; Tayeb Nayeri; Daniel Aili; Bo Liedberg; Uno Carlsson
Journal:  J Dermatol Sci       Date:  2006-04-18       Impact factor: 4.563

3.  Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase.

Authors:  Mitsuru Machide; Atsuko Hashigasako; Kunio Matsumoto; Toshikazu Nakamura
Journal:  J Biol Chem       Date:  2006-01-16       Impact factor: 5.157

Review 4.  The Met pathway: master switch and drug target in cancer progression.

Authors:  Massimiliano Mazzone; Paolo M Comoglio
Journal:  FASEB J       Date:  2006-08       Impact factor: 5.191

Review 5.  From Tpr-Met to Met, tumorigenesis and tubes.

Authors:  P Peschard; M Park
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

6.  Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.

Authors:  Bin Hui; Wei Xia; Jing Li; Limei Wang; Jing Ai; Meiyu Geng
Journal:  J Neurochem       Date:  2006-03-15       Impact factor: 5.372

7.  Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development.

Authors:  Sebastian Bäumer; Linda Keller; Astrid Holtmann; Ruth Funke; Benjamin August; Alexander Gamp; Hartwig Wolburg; Karen Wolburg-Buchholz; Urban Deutsch; Dietmar Vestweber
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

8.  Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis.

Authors:  Melissa G Dominguez; Virginia C Hughes; Li Pan; Mary Simmons; Christopher Daly; Keith Anderson; Irene Noguera-Troise; Andrew J Murphy; David M Valenzuela; Samuel Davis; Gavin Thurston; George D Yancopoulos; Nicholas W Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

9.  Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.

Authors:  E D Fixman; M A Naujokas; G A Rodrigues; M F Moran; M Park
Journal:  Oncogene       Date:  1995-01-19       Impact factor: 9.867

10.  c-Met is essential for wound healing in the skin.

Authors:  Jolanta Chmielowiec; Malgorzata Borowiak; Markus Morkel; Theresia Stradal; Barbara Munz; Sabine Werner; Jürgen Wehland; Carmen Birchmeier; Walter Birchmeier
Journal:  J Cell Biol       Date:  2007-04-02       Impact factor: 10.539

View more
  13 in total

1.  Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer.

Authors:  Deping Zhao; Yi Lu; Chenlu Yang; Xiao Zhou; Zhifei Xu
Journal:  Tumour Biol       Date:  2015-01-08

Review 2.  Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack.

Authors:  Alma N Mohebiany; Roman M Nikolaienko; Samuel Bouyain; Sheila Harroch
Journal:  FEBS J       Date:  2012-07-05       Impact factor: 5.542

3.  Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma.

Authors:  Jiajun Wang; Hongying Su; Xiangjun Han; Ke Xu
Journal:  Tumour Biol       Date:  2014-08-05

Review 4.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

5.  Expression of catalytically active matrix metalloproteinase-1 in dermal fibroblasts induces collagen fragmentation and functional alterations that resemble aged human skin.

Authors:  Wei Xia; Craig Hammerberg; Yong Li; Tianyuan He; Taihao Quan; John J Voorhees; Gary J Fisher
Journal:  Aging Cell       Date:  2013-05-15       Impact factor: 9.304

6.  Hydroxyindole carboxylic acid-based inhibitors for receptor-type protein tyrosine protein phosphatase beta.

Authors:  Li-Fan Zeng; Ruo-Yu Zhang; Yunpeng Bai; Li Wu; Andrea M Gunawan; Zhong-Yin Zhang
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

7.  Normal sulfation levels regulate spinal cord neural precursor cell proliferation and differentiation.

Authors:  Michael Karus; Samira Samtleben; Claudia Busse; Teresa Tsai; Irmgard D Dietzel; Andreas Faissner; Stefan Wiese
Journal:  Neural Dev       Date:  2012-06-08       Impact factor: 3.842

Review 8.  MET targeting: time for a rematch.

Authors:  Jonas P Koch; Daniel M Aebersold; Yitzhak Zimmer; Michaela Medová
Journal:  Oncogene       Date:  2020-02-07       Impact factor: 8.756

9.  Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes.

Authors:  Elizabeth Bloch; Eden L Sikorski; David Pontoriero; Evan K Day; Bryan W Berger; Matthew J Lazzara; Damien Thévenin
Journal:  J Biol Chem       Date:  2019-11-01       Impact factor: 5.486

10.  Role of met axis in head and neck cancer.

Authors:  Yiru Xu; Gary J Fisher
Journal:  Cancers (Basel)       Date:  2013-11-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.